| SIU School of Medicine

News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.

News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.

News

Southern Illinois University officially among top research schools in U.S.

SIU has officially entered the ranks of the top research universities in the nation: It has been designated Research 1, or R1, in the Carnegie Classifications of Institutions of Higher Education.

News

Medical student assists at accident scene

An automobile rollover on the interstate gave first-year medical student Carson Schaefer an opportunity to use his training to assess and treat trauma.

News

Medical student assists at accident scene

An automobile rollover on the interstate gave first-year medical student Carson Schaefer an opportunity to use his training to assess and treat trauma.

News

Medical student assists at accident scene

An automobile rollover on the interstate gave first-year medical student Carson Schaefer an opportunity to use his training to assess and treat trauma.

News

Medical student assists at accident scene

An automobile rollover on the interstate gave first-year medical student Carson Schaefer an opportunity to use his training to assess and treat trauma.

News

Medical student assists at accident scene

An automobile rollover on the interstate gave first-year medical student Carson Schaefer an opportunity to use his training to assess and treat trauma.

News

Medical student assists at accident scene

An automobile rollover on the interstate gave first-year medical student Carson Schaefer an opportunity to use his training to assess and treat trauma.

Trial

Simmons Cancer Institute

BC-IMT-04: Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)

Active recruiting

This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.

Subscribe to